Stock comparison
IDEXX Laboratories
Koninklijke Philips N.V.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
PHG
Koninklijke Philips N.V.
Market cap
$25.66B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | PHG | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 38D | IDXX |
| Benjamin Graham | 80A | 36D | IDXX |
| Philip Fisher | 75B | 38D | IDXX |
| Peter Lynch | 71B | 44D | IDXX |
| Joel Greenblatt | 83C | 30F | IDXX |
| Charlie Munger | 87A | 36D | IDXX |
| Terry Smith | 84A | 33F | IDXX |
Side-by-side metrics
| Metric | IDXX | PHG |
|---|---|---|
| Market cap | $44.12B | $25.66B |
| P/E (TTM) | 39.0x | 21.4x |
| EV/EBIT | 31.6x | 18.5x |
| ROIC (TTM) | 40.66% | 5.76% |
| Gross margin | 62.05% | 45.2% |
| Net margin | 24.63% | 5.5% |
| Revenue CAGR 5y | 7.56% | 0.97% |
| EPS CAGR 5y | 10.79% | 9.12% |
| Debt / Equity | 0.7x | 0.7x |
| Dividend yield | 0.0% | 3.89% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Revenue CAGR 5y7.56%vs 0.97%+87%
- ROIC (TTM)40.66%vs 5.76%+86%
- Net margin24.63%vs 5.5%+78%
- Market cap$44.12Bvs $25.66B+42%
PHG leads on
- Dividend yield3.89%vs 0.0%+100%
- P/E (TTM)21.4xvs 39.0x+45%
- EV/EBIT18.5xvs 31.6x+42%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.